Announcements Trials
Browse Landscape

Phase

Phase NA 19Phase 3 9Phase 2 3Phase 4 2Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 6Genitourinary 5Gastrointestinal 5Lymphoid 4Thoracic 2Sarcoma 2Other 2Head & Neck 2Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 88Lung Neoplasms 70Small Cell Lung Carcinoma 11Pleural Effusion, Malignant 9Melanoma 7Ovarian Neoplasms 6NSCLC 6Pleural Effusion 5Neoplasms 5Head and Neck Neoplasms 5Stomach Neoplasms 4Mesothelioma 4Lung Diseases 4Carcinoma, Renal Cell 4Carcinoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Thoracic Neoplasms 3Pneumothorax 3Pleural Neoplasms 3Pancreatic Neoplasms 3Non-Squamous Non-Small Cell Lung Cancer 3Neoplasm Metastasis 3Liver Neoplasms 3Kidney Neoplasms 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Venous Thromboembolism 2Urinary Bladder Neoplasms 2

Interventions

Fentanyl 1Bupivacaine 1Anti-Inflammatory Agents, Non-Steroidal 1Analgesics, Opioid 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Pain × Thoracic × Clear all
NCT02359175 2023-06-27

SEAVATS

Odense University Hospital

Phase 4 Completed
161 enrolled
Thoracic

Lung Neoplasms, Pain

NCT01060137 2010-02-05

Fentanyl Matrix in Lung Cancer Pain

Janssen Korea, Ltd., Korea

Phase 4 Completed
268 enrolled
Thoracic

Lung Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡